Sintilimab plus cisplatin and nab‐paclitaxel induction treatment for locally advanced borderline‐resectable oesophageal squamous cell carcinoma: A single‐arm, prospective, phase 2 study (NEOCRTEC2001).
Saved in:
| Title: | Sintilimab plus cisplatin and nab‐paclitaxel induction treatment for locally advanced borderline‐resectable oesophageal squamous cell carcinoma: A single‐arm, prospective, phase 2 study (NEOCRTEC2001). |
|---|---|
| Authors: | Wu, Jia‐Di1 (AUTHOR), Wang, De‐Shen1 (AUTHOR), Wang, Zhi‐Qiang1 (AUTHOR), Li, Qiao‐Qiao1 (AUTHOR), Xu, Bin‐Yang2 (AUTHOR), Ren, Chao1 (AUTHOR), Fang, Cai‐Yan1 (AUTHOR), Huang, Yan1 (AUTHOR), Li, Zhi‐Chao1 (AUTHOR), Chen, Ji‐Yang1 (AUTHOR), Tan, Qiong1 (AUTHOR), Li, Yu‐Hong1 (AUTHOR) liyh@sysucc.org.cn, Yang, Hong1 (AUTHOR) yanghong@sysucc.org.cn |
| Source: | Clinical & Translational Medicine. May2026, Vol. 16 Issue 5, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20011326 |
|---|---|
| DOI: | 10.1002/ctm2.70691 |
